Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 1

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 1
---
 anti-inflammatory eye drop
                                            indicated for pain and inflammation associated with cataract surgery.

 4 

·FLAREX®
                                            (fluorometholone acetate ophthalmic suspension) 0.1%, a corticosteroid prepared as
                                            a sterile topical ophthalmic suspension indicated for use in the treatment of steroid-responsive
                                            inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment
                                            of the eye.

·NATACYN®
                                            (natamycin ophthalmic suspension) 5%, a sterile, antifungal drug for the treatment
                                            of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms, including
                                            Fusarium solani keratitis.

·TOBRADEX®
                                            ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, a topical antibiotic
                                            and corticosteroid combination for steroid-responsive inflammatory ocular conditions for
                                            which a corticosteroid is indicated and where superficial bacterial ocular infection or a
                                            risk of bacterial ocular infection exists.

·ZERVIATE®
                                            (cetirizine ophthalmic solution) 0.24%, a histamine-1 (H1) receptor antagonist indicated
                                            for treatment of ocular itching associated with allergic conjunctivitis.

·VERKAZIA®
                                            (cyclosporine ophthalmic emulsion) 0.1%, an orphan designated drug that is a calcineurin
                                            inhibitor immunosuppressant indicated for the treatment of vernal keratoconjunctivitis.

·NEVANAC®
                                            (nepafenac ophthalmic suspension) 0.1%, a non-steroidal, anti-inflammatory eye drop
                                            indicated for pain and inflammation associated with cataract surgery.

·FRESHKOTE®
                                            Preservative Free (PF) is a lubricant eye drop that does not require a prescription
                                            and temporarily relieves burning, itching and other dry eye symptoms.

·MAXITROL®
                                            (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension) is an eye
                                            drop used to treat steroid-responsive inflammatory ocular conditions where bacterial infection
                                            or a risk of bacterial ocular infection exist.

·MAXIDEX®
                                            (d